SynPlex Technology is a patent-pending process used in the formulation of AVIA making it the world’s first time-released health supplement. AVIA is Synaura’s flagship product; formulated by Harvard MD, Dr. Kenneth Kroll – a liquid supplement containing the maqui berry as its primary ingredient.

SynPlex Technology consists of thousands of tiny microcapsules suspended within the liquid. Each microcapsule contains an ingredient shown in scientific studies to be a powerful anti-inflammatory and powerful antioxidant. This encapsulation of these nutrients provides long lasting protection against inflammation and oxidation. Other liquid supplements typically have a much shorter half-life.

The shells of the capsules vary in size, specifically in the thickness of the shells, and are PH sensitive allowing for a slow release of nutrients in the body at different time intervals. Instead of one big rush of nutrients, the microcapsules allow for a more balanced approach towards your overall health.

This technology is the first to successfully creating a time-released health supplement. And Synaura is the first to make it available to the world. AVIA is not just another juice or super fruit. AVIA is the next generation in liquid supplements with a scientifically balanced formula. AVIA is a category creator, not just another “drink”.

SynPlex Technology is just one of the innovations Synaura has created. Do you know that Synaura is also the first company to bring the revered maqui berry to the world? They’re just getting started and this technology is just an example of the company’s progressive philosophy.

Next Post: Patagonian Maqui Berry Story Revealed by Synaura